Ian Roman Rifkin, M.B.,B.Ch., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interferon Regulatory Factors | 11 | 2021 | 270 | 3.400 |
Why?
|
| Lupus Erythematosus, Systemic | 18 | 2021 | 2099 | 1.990 |
Why?
|
| Antigen-Antibody Complex | 6 | 2009 | 517 | 0.960 |
Why?
|
| Dendritic Cells | 8 | 2020 | 2723 | 0.950 |
Why?
|
| Toll-Like Receptor 7 | 8 | 2023 | 172 | 0.920 |
Why?
|
| B-Lymphocytes | 11 | 2021 | 4664 | 0.900 |
Why?
|
| Toll-Like Receptor 9 | 13 | 2015 | 212 | 0.780 |
Why?
|
| Lupus Nephritis | 3 | 2017 | 310 | 0.740 |
Why?
|
| GTPase-Activating Proteins | 2 | 2014 | 497 | 0.730 |
Why?
|
| Autoimmune Diseases | 10 | 2010 | 2130 | 0.670 |
Why?
|
| PPAR gamma | 2 | 2014 | 493 | 0.660 |
Why?
|
| Thiazolidinediones | 2 | 2014 | 476 | 0.650 |
Why?
|
| Toll-Like Receptor 3 | 2 | 2015 | 91 | 0.610 |
Why?
|
| Membrane Glycoproteins | 9 | 2015 | 3769 | 0.580 |
Why?
|
| Interleukin-6 | 3 | 2021 | 3199 | 0.560 |
Why?
|
| Rheumatoid Factor | 5 | 2006 | 188 | 0.540 |
Why?
|
| CpG Islands | 4 | 2015 | 1170 | 0.530 |
Why?
|
| Toll-Like Receptors | 8 | 2017 | 592 | 0.510 |
Why?
|
| Mice, Knockout | 21 | 2019 | 14554 | 0.510 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2015 | 315 | 0.490 |
Why?
|
| Receptors, Cell Surface | 7 | 2005 | 2867 | 0.490 |
Why?
|
| Autoimmunity | 8 | 2021 | 1348 | 0.480 |
Why?
|
| Helminth Proteins | 1 | 2015 | 171 | 0.480 |
Why?
|
| Receptors, IgG | 2 | 2009 | 582 | 0.470 |
Why?
|
| Arthritis, Experimental | 1 | 2015 | 291 | 0.450 |
Why?
|
| Podocytes | 1 | 2017 | 394 | 0.450 |
Why?
|
| Lymphocyte Activation | 11 | 2009 | 5519 | 0.440 |
Why?
|
| Immunoglobulin G | 9 | 2009 | 4554 | 0.430 |
Why?
|
| Mice, Inbred MRL lpr | 9 | 2014 | 159 | 0.420 |
Why?
|
| Atherosclerosis | 5 | 2015 | 3428 | 0.410 |
Why?
|
| Autoantigens | 5 | 2017 | 891 | 0.400 |
Why?
|
| Nucleic Acids | 1 | 2014 | 181 | 0.390 |
Why?
|
| Myeloid Cells | 1 | 2015 | 804 | 0.380 |
Why?
|
| Interferon-alpha | 5 | 2017 | 895 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2021 | 4414 | 0.370 |
Why?
|
| Interferon-beta | 2 | 2009 | 323 | 0.370 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2015 | 561 | 0.370 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2009 | 10 | 0.360 |
Why?
|
| Mice | 37 | 2023 | 81045 | 0.340 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 2009 | 708 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 17 | 2017 | 21821 | 0.320 |
Why?
|
| Disease Models, Animal | 15 | 2021 | 18006 | 0.310 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2007 | 39 | 0.300 |
Why?
|
| Interferon Type I | 2 | 2010 | 542 | 0.300 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2006 | 547 | 0.290 |
Why?
|
| DNA | 7 | 2015 | 7289 | 0.270 |
Why?
|
| Immunologic Factors | 1 | 2015 | 1575 | 0.260 |
Why?
|
| Animals | 42 | 2023 | 168561 | 0.260 |
Why?
|
| Glomerulonephritis | 2 | 2023 | 372 | 0.250 |
Why?
|
| DNA-Binding Proteins | 6 | 2007 | 9639 | 0.250 |
Why?
|
| RNA | 4 | 2007 | 2747 | 0.250 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2003 | 246 | 0.220 |
Why?
|
| Adiponectin | 1 | 2009 | 1099 | 0.220 |
Why?
|
| Ligands | 7 | 2017 | 3293 | 0.210 |
Why?
|
| Fas Ligand Protein | 4 | 2013 | 217 | 0.210 |
Why?
|
| Th2 Cells | 5 | 2020 | 1049 | 0.210 |
Why?
|
| Autoantibodies | 7 | 2014 | 2036 | 0.200 |
Why?
|
| Monocytes | 3 | 2015 | 2593 | 0.200 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2003 | 291 | 0.200 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2211 | 0.190 |
Why?
|
| Epidermal Growth Factor | 1 | 2023 | 709 | 0.180 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2015 | 3695 | 0.180 |
Why?
|
| Epitopes | 1 | 2007 | 2569 | 0.180 |
Why?
|
| Apolipoproteins E | 4 | 2014 | 1438 | 0.180 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2014 | 581 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2019 | 119 | 0.170 |
Why?
|
| Spleen | 3 | 2014 | 2359 | 0.170 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2020 | 78 | 0.170 |
Why?
|
| Cytokines | 6 | 2020 | 7317 | 0.170 |
Why?
|
| Antibodies, Antinuclear | 3 | 2015 | 326 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4379 | 0.160 |
Why?
|
| Germinal Center | 1 | 2021 | 377 | 0.160 |
Why?
|
| Chromatin | 4 | 2004 | 2917 | 0.160 |
Why?
|
| Th1 Cells | 4 | 2014 | 1056 | 0.150 |
Why?
|
| Mice, Transgenic | 9 | 2017 | 9735 | 0.150 |
Why?
|
| Immunoglobulin E | 1 | 2003 | 1460 | 0.150 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2017 | 53 | 0.140 |
Why?
|
| Toll-Like Receptor 8 | 2 | 2015 | 90 | 0.140 |
Why?
|
| Spores, Bacterial | 1 | 2017 | 118 | 0.140 |
Why?
|
| Signal Transduction | 9 | 2021 | 23387 | 0.140 |
Why?
|
| Proteinuria | 2 | 2017 | 657 | 0.130 |
Why?
|
| Macrophages | 5 | 2023 | 5655 | 0.130 |
Why?
|
| Rolipram | 1 | 2015 | 27 | 0.130 |
Why?
|
| RNA, Bacterial | 1 | 2017 | 391 | 0.130 |
Why?
|
| Osmosis | 2 | 2015 | 113 | 0.130 |
Why?
|
| Transgenes | 1 | 1998 | 1009 | 0.130 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2015 | 43 | 0.130 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1998 | 525 | 0.130 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2015 | 34 | 0.130 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2015 | 261 | 0.120 |
Why?
|
| B-Cell Activating Factor | 1 | 2014 | 119 | 0.120 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2014 | 158 | 0.120 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 2 | 1993 | 29 | 0.120 |
Why?
|
| Neutrophil Activation | 1 | 2014 | 186 | 0.120 |
Why?
|
| Synovial Fluid | 1 | 2015 | 394 | 0.120 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2015 | 354 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 4 | 2009 | 6382 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 1333 | 0.110 |
Why?
|
| Th17 Cells | 1 | 2020 | 765 | 0.110 |
Why?
|
| Trans-Activators | 1 | 2003 | 2924 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2017 | 493 | 0.110 |
Why?
|
| Cells, Cultured | 8 | 2015 | 19223 | 0.110 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 1993 | 126 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2015 | 558 | 0.100 |
Why?
|
| Mycophenolic Acid | 1 | 2013 | 343 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1655 | 0.100 |
Why?
|
| Flow Cytometry | 3 | 2017 | 5975 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1860 | 0.090 |
Why?
|
| Poly I-C | 1 | 2010 | 115 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 972 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 3164 | 0.090 |
Why?
|
| Rhabdomyolysis | 1 | 1991 | 150 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 12071 | 0.090 |
Why?
|
| Models, Immunological | 2 | 2004 | 527 | 0.090 |
Why?
|
| Immunosuppressive Agents | 3 | 2013 | 4147 | 0.080 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 242 | 0.080 |
Why?
|
| Nucleosomes | 2 | 2004 | 493 | 0.080 |
Why?
|
| Cell-Free System | 1 | 2009 | 344 | 0.080 |
Why?
|
| Dermatitis | 1 | 2010 | 197 | 0.080 |
Why?
|
| Levocardia | 1 | 1987 | 2 | 0.080 |
Why?
|
| Hybridomas | 2 | 2006 | 452 | 0.080 |
Why?
|
| Immunity, Innate | 3 | 2010 | 2956 | 0.080 |
Why?
|
| Fibrosis | 1 | 2015 | 2026 | 0.080 |
Why?
|
| Lithium | 1 | 1991 | 601 | 0.080 |
Why?
|
| Neutrophils | 3 | 2014 | 3711 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 15530 | 0.070 |
Why?
|
| Apoptosis | 4 | 2015 | 9715 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 479 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 313 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 2 | 2009 | 1000 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4438 | 0.070 |
Why?
|
| DNA Primers | 3 | 2006 | 2892 | 0.070 |
Why?
|
| Splenomegaly | 2 | 2013 | 190 | 0.070 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2006 | 276 | 0.070 |
Why?
|
| Mutation | 4 | 2014 | 29717 | 0.070 |
Why?
|
| Humans | 39 | 2023 | 742088 | 0.060 |
Why?
|
| Vena Cava, Inferior | 1 | 1987 | 436 | 0.060 |
Why?
|
| Lymphatic Diseases | 2 | 2013 | 324 | 0.060 |
Why?
|
| Lymphocyte Depletion | 1 | 2006 | 608 | 0.060 |
Why?
|
| Gene Expression | 2 | 2014 | 7790 | 0.060 |
Why?
|
| Simvastatin | 1 | 2006 | 360 | 0.060 |
Why?
|
| Immunoglobulin M | 3 | 2006 | 1538 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1596 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2020 | 1470 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2006 | 659 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2003 | 12164 | 0.060 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 1699 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 3862 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2014 | 2145 | 0.060 |
Why?
|
| Base Sequence | 4 | 2015 | 12797 | 0.060 |
Why?
|
| Macrolides | 1 | 2004 | 201 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 2006 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2006 | 880 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 320 | 0.050 |
Why?
|
| Aging | 1 | 2021 | 8626 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2014 | 10248 | 0.050 |
Why?
|
| Psoriasis | 1 | 2009 | 898 | 0.050 |
Why?
|
| Skin | 1 | 2015 | 4353 | 0.050 |
Why?
|
| Immunoglobulin Allotypes | 1 | 2000 | 56 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2003 | 471 | 0.050 |
Why?
|
| Haptens | 1 | 2000 | 166 | 0.050 |
Why?
|
| Immune Sera | 1 | 2000 | 641 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 6754 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 2006 | 2513 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 1889 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 1092 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2004 | 1264 | 0.040 |
Why?
|
| Phenotype | 3 | 2013 | 16331 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 2000 | 742 | 0.040 |
Why?
|
| Cattle | 1 | 2004 | 3923 | 0.040 |
Why?
|
| Casein Kinase II | 1 | 1998 | 128 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 1586 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 2006 | 3465 | 0.040 |
Why?
|
| Male | 12 | 2021 | 349538 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 16665 | 0.040 |
Why?
|
| Bacillus anthracis | 1 | 2017 | 123 | 0.040 |
Why?
|
| Cell Line | 2 | 2009 | 15994 | 0.030 |
Why?
|
| Progesterone | 3 | 1977 | 773 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2009 | 4282 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2019 | 1011 | 0.030 |
Why?
|
| Genotype | 1 | 2009 | 12946 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2000 | 1355 | 0.030 |
Why?
|
| Interferon-gamma | 2 | 2015 | 3199 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 1866 | 0.030 |
Why?
|
| Diphtheria Toxin | 1 | 2015 | 255 | 0.030 |
Why?
|
| Homozygote | 1 | 1998 | 1777 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1905 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 2015 | 214 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 275 | 0.030 |
Why?
|
| Female | 14 | 2021 | 379592 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 438 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 1999 | 1284 | 0.030 |
Why?
|
| Dialysis Solutions | 1 | 1993 | 39 | 0.030 |
Why?
|
| Calcium Carbonate | 1 | 1993 | 67 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3800 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2015 | 711 | 0.030 |
Why?
|
| Inflammation | 2 | 2015 | 10578 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 158 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 11363 | 0.030 |
Why?
|
| Heterozygote | 1 | 1998 | 2790 | 0.030 |
Why?
|
| Ovary | 2 | 1976 | 981 | 0.030 |
Why?
|
| Liver | 1 | 1987 | 7470 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2014 | 4211 | 0.030 |
Why?
|
| Renal Veins | 1 | 1992 | 108 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2007 | 9144 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 1987 | 4566 | 0.020 |
Why?
|
| Antigens, Differentiation | 2 | 2005 | 926 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 1969 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2015 | 10472 | 0.020 |
Why?
|
| Chemokines | 1 | 2015 | 954 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1998 | 1837 | 0.020 |
Why?
|
| Lithium Carbonate | 1 | 1991 | 184 | 0.020 |
Why?
|
| Hypercalcemia | 1 | 1993 | 405 | 0.020 |
Why?
|
| Postpartum Period | 2 | 1977 | 1078 | 0.020 |
Why?
|
| Calcium | 2 | 1994 | 5753 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2005 | 571 | 0.020 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2010 | 58 | 0.020 |
Why?
|
| Renal Artery | 1 | 1992 | 398 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 9410 | 0.020 |
Why?
|
| Thalidomide | 1 | 1995 | 888 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1972 | 563 | 0.020 |
Why?
|
| Magnesium | 1 | 1993 | 813 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1995 | 986 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2015 | 1200 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1996 | 1835 | 0.020 |
Why?
|
| Phosphates | 1 | 1993 | 786 | 0.020 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2009 | 107 | 0.020 |
Why?
|
| Dermis | 1 | 2010 | 207 | 0.020 |
Why?
|
| Estrogens | 1 | 1975 | 1562 | 0.020 |
Why?
|
| Amenorrhea | 1 | 1972 | 485 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1992 | 315 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8436 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1782 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 1477 | 0.020 |
Why?
|
| Immune System Diseases | 1 | 2010 | 262 | 0.020 |
Why?
|
| Receptors, Immunologic | 2 | 2005 | 1423 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2000 | 2951 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3564 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2699 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 6171 | 0.020 |
Why?
|
| Corpus Luteum | 2 | 1977 | 86 | 0.020 |
Why?
|
| Cholesterol | 2 | 2006 | 2895 | 0.020 |
Why?
|
| Eating | 1 | 2013 | 1535 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 1993 | 1801 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1993 | 3139 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 970 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 14720 | 0.020 |
Why?
|
| Hematuria | 1 | 2006 | 235 | 0.020 |
Why?
|
| Prognosis | 1 | 2006 | 29010 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2000 | 9274 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 1991 | 893 | 0.020 |
Why?
|
| Immune System | 1 | 2010 | 804 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2000 | 10163 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 57683 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 2006 | 697 | 0.010 |
Why?
|
| Antigens, Nuclear | 1 | 2004 | 192 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8425 | 0.010 |
Why?
|
| Ovulation | 2 | 1976 | 189 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4801 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2005 | 2915 | 0.010 |
Why?
|
| Kinetics | 2 | 2006 | 6474 | 0.010 |
Why?
|
| Ribonucleoproteins | 1 | 2005 | 381 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 964 | 0.010 |
Why?
|
| Body Weight | 1 | 2013 | 4664 | 0.010 |
Why?
|
| Receptors, Complement 3d | 1 | 2002 | 118 | 0.010 |
Why?
|
| Receptors, Complement 3b | 1 | 2002 | 145 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1849 | 0.010 |
Why?
|
| Adult | 6 | 2021 | 213712 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 2002 | 228 | 0.010 |
Why?
|
| Chloroquine | 1 | 2003 | 280 | 0.010 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 2 | 1994 | 286 | 0.010 |
Why?
|
| Creatinine | 1 | 2006 | 1916 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1993 | 4455 | 0.010 |
Why?
|
| Mammals | 1 | 2006 | 1135 | 0.010 |
Why?
|
| Kidney Transplantation | 2 | 1992 | 4246 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1992 | 2536 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4328 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2010 | 4143 | 0.010 |
Why?
|
| Wasting Syndrome | 1 | 2000 | 101 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 5019 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 17400 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 1991 | 1967 | 0.010 |
Why?
|
| Middle Aged | 4 | 2021 | 213127 | 0.010 |
Why?
|
| Relaxin | 1 | 1977 | 36 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2004 | 1149 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 162944 | 0.010 |
Why?
|
| Bee Venoms | 1 | 1996 | 14 | 0.010 |
Why?
|
| Mites | 1 | 1996 | 43 | 0.010 |
Why?
|
| Menotropins | 1 | 1976 | 45 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13256 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 2057 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 1263 | 0.010 |
Why?
|
| Mitogens | 1 | 1996 | 232 | 0.010 |
Why?
|
| Fertility Agents, Female | 1 | 1976 | 99 | 0.010 |
Why?
|
| Estrone | 1 | 1975 | 239 | 0.010 |
Why?
|
| Calcimycin | 1 | 1994 | 222 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1976 | 474 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1994 | 149 | 0.010 |
Why?
|
| Polyarteritis Nodosa | 1 | 1994 | 66 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1991 | 5024 | 0.010 |
Why?
|
| Dust | 1 | 1996 | 479 | 0.010 |
Why?
|
| Menarche | 1 | 1976 | 513 | 0.010 |
Why?
|
| Norethynodrel | 1 | 1972 | 2 | 0.010 |
Why?
|
| Mestranol | 1 | 1972 | 9 | 0.010 |
Why?
|
| Ethynodiol Diacetate | 1 | 1972 | 5 | 0.010 |
Why?
|
| 17-Ketosteroids | 1 | 1972 | 39 | 0.010 |
Why?
|
| Cervix Mucus | 1 | 1972 | 18 | 0.010 |
Why?
|
| Sperm Capacitation | 1 | 1972 | 26 | 0.010 |
Why?
|
| Receptors, Somatotropin | 1 | 1992 | 76 | 0.010 |
Why?
|
| Norethindrone | 1 | 1972 | 59 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1993 | 433 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1992 | 668 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1995 | 784 | 0.010 |
Why?
|
| Estradiol | 2 | 1976 | 2021 | 0.010 |
Why?
|
| Renal Circulation | 1 | 1992 | 333 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15494 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1993 | 482 | 0.010 |
Why?
|
| Ultrasonics | 1 | 1992 | 212 | 0.010 |
Why?
|
| Cesarean Section | 2 | 1977 | 1363 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1992 | 703 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1972 | 738 | 0.010 |
Why?
|
| Endometrium | 1 | 1972 | 424 | 0.010 |
Why?
|
| Body Temperature | 1 | 1972 | 776 | 0.010 |
Why?
|
| Parity | 1 | 1972 | 929 | 0.010 |
Why?
|
| Allergens | 1 | 1996 | 1314 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1992 | 1423 | 0.000 |
Why?
|
| Hypersensitivity | 1 | 1996 | 1093 | 0.000 |
Why?
|
| Stem Cells | 1 | 2000 | 3563 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1972 | 1961 | 0.000 |
Why?
|
| Kidney | 2 | 1992 | 7167 | 0.000 |
Why?
|
| Propylene Glycol | 1 | 1946 | 32 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1992 | 1780 | 0.000 |
Why?
|
| Penicillins | 1 | 1946 | 378 | 0.000 |
Why?
|
| Time Factors | 2 | 1996 | 40054 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1993 | 4024 | 0.000 |
Why?
|
| Biopsy | 1 | 1992 | 6756 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1992 | 5978 | 0.000 |
Why?
|
| Pregnancy | 2 | 1977 | 29087 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1976 | 326 | 0.000 |
Why?
|
| Abortion, Legal | 1 | 1977 | 116 | 0.000 |
Why?
|
| Haplorhini | 1 | 1976 | 551 | 0.000 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1977 | 732 | 0.000 |
Why?
|
| Sexual Maturation | 1 | 1976 | 265 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1976 | 2378 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1992 | 15244 | 0.000 |
Why?
|
| Alkenes | 1 | 1946 | 57 | 0.000 |
Why?
|